Part of the series: Allergy, Asthma & Immunology Innovations Podcast

This podcast was made in partnership with Allergy & Asthma Network, with funding support from AstraZeneca.

In this episode, we explore a new form of asthma treatment, Biologics. These innovative treatments offer targeted relief by addressing the underlying causes of asthma, leading to improved symptom control and a better quality of life. Dr. G and Kortney discuss the current biologics on the market for asthma treatment.

As this is a true deep dive, we have provided some more information about the Biologics discussed to help you build a better understanding. We have included images and graphs you can use when listening to the episode.

What we cover in this episode:

• A background on how Biologic treatments work.
• The Biologics available for asthma - discuss who is a candidate, how they each work, how they are taken and some side effects.
  • Omalizumab (Xolair)
  • Mepolizumab
  • Reslizumab
  • Benralizumab
  • Dupilumab
  • Tezepelumab

Helpful links:

Images and graphs discussed in this episode: www.itchpodcast.com/episodes/56-asthma-biologics

A look at biologics in more depth: www.biologicmeds.org

More about type 2 inflammation: https://allergyasthmanetwork.org/news/when-asthma-more-than-asthma-type-inflammation/